| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.26 | 3e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |